Athanasiadou Kleoniki I, Paschou Stavroula A, Markozannes Georgios, Vasileiou Vasiliki, Kanouta Fotini, Mitropoulou Marina, Antsaklis Panagiotis, Theodora Mariana, Psaltopoulou Theodora, Daskalakis George, Goulis Dimitrios G, Anastasiou Eleni
Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, University Campus, Ioannina, Greece.
Endocrine. 2025 Jun 26. doi: 10.1007/s12020-025-04329-1.
To determine whether the abnormal glucose concentrations at various oral glucose tolerance test (OGTT) time points are associated with adverse perinatal outcomes in pregnancies complicated by gestational diabetes mellitus (GDM).
A retrospective study included 257 pregnant women with GDM (IADPSG criteria) who delivered between 2020-2023 at a tertiary hospital. Women were classified based on their OGTT results: isolated fasting hyperglycemia (group A), isolated post-load hyperglycemia (group B), and combined hyperglycemia (group C). Multivariable linear and logistic regression analyses were performed.
Most women had fasting hyperglycemia (54.1%), followed by isolated post-load hyperglycemia (29.2%), and combined hyperglycemia (16.7%). In the univariate analysis, women in Groups A and C had higher BMI before pregnancy (29.0 [7.6] kg/m and 30.6 [9.3] kg/m, respectively) compared with women in Group B (26.3 [6.2] kg/m). Groups A and C had a higher prevalence of insulin use compared with Group B (81.3 and 88.4% vs. 49.3%, p < 0.001). Their neonates had higher birth weights (3221 ± 525 g and 3208 ± 512 g vs. 3030 ± 591 g, p = 0.039) and higher rates of large-for-gestational-age (11.5 and 16.3% vs. 2.7%, p = 0.032). However, the multivariable analyses did not show significant differences among the groups.
The GDM subtypes identified through the OGTT were related to distinct metabolic phenotypes and pregnancy outcomes, indicating the presence of heterogeneity in GDM. Future studies are required to confirm these findings and explore whether the OGTT could be used to guide individualized GDM treatment.
确定在妊娠期糖尿病(GDM)合并妊娠中,不同口服葡萄糖耐量试验(OGTT)时间点的异常血糖浓度是否与不良围产期结局相关。
一项回顾性研究纳入了2020年至2023年在一家三级医院分娩的257例符合国际糖尿病和妊娠研究组协会(IADPSG)标准的GDM孕妇。根据她们的OGTT结果进行分类:单纯空腹血糖升高(A组)、单纯负荷后血糖升高(B组)和联合血糖升高(C组)。进行了多变量线性和逻辑回归分析。
大多数女性存在空腹血糖升高(54.1%),其次是单纯负荷后血糖升高(29.2%)和联合血糖升高(16.7%)。在单变量分析中,与B组女性(26.3[6.2]kg/m²)相比,A组和C组女性孕前BMI更高(分别为29.0[7.6]kg/m²和30.6[9.3]kg/m²)。与B组相比,A组和C组胰岛素使用的患病率更高(81.3%和88.4%对49.3%,p<0.001)。她们的新生儿出生体重更高(3221±525g和3208±512g对3030±591g,p=0.039),大于胎龄儿的发生率更高(11.5%和16.3%对2.7%,p=0.032)。然而,多变量分析未显示各组之间存在显著差异。
通过OGTT确定的GDM亚型与不同的代谢表型和妊娠结局相关,表明GDM存在异质性。未来需要进一步研究来证实这些发现,并探索OGTT是否可用于指导GDM的个体化治疗。